Evaluation of Breast Disorders - Gynecology and Obstetrics - Merck

Description

Brought to you by Merck & Co, Inc., Rahway, NJ, USA (known as MSD outside the US and Canada) —dedicated to using leading-edge science to save and improve lives around the world. Learn more about the Merck Manuals and our commitment to Global Medical Knowledge.

Nipple Discharge: Causes, Symptoms, and Treatment

Evolutionary histories of breast cancer and related clones

Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling

Breast Imaging Devices Market Size, Share, Growth Drivers 2033

Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy

Breast disorders2 8-11

The Clinical Impact of the Women's Health Initiative (WHI): Entering a New Era in Managing Postmenopausal Health Issues

The Clinical Impact of the Women's Health Initiative (WHI): Entering a New Era in Managing Postmenopausal Health Issues

Expanding options for HER2 advanced breast cancer: Taking trial data to the clinic - touchONCOLOGY

Breast disorders2 8-11

$ 13.99USD
Score 4.6(379)
In stock
Continue to book